Profiel
Claire J.
Lockey formerly worked at Titan Pharmaceuticals, Inc., as Vice President-Regulatory Affairs, Connetics Corp., as Principal, Tricida, Inc., as Chief Development Officer & Senior Vice President from 2016 to 2019, FibroGen, Inc., as Vice President-Regulatory Affairs from 2003 to 2010, Layton BioScience, Inc., as Principal, Relypsa, Inc., as Senior Vice President-Regulatory Affairs from 2012 to 2015, Synergia LLC, as Principal from 1985 to 1995, and Gore Hybrid Technologies, Inc., as Principal.
Ms. Lockey received her undergraduate degree from Boston University.
Eerdere bekende functies van Claire J. Lockey
| Bedrijven | Functie | Einde |
|---|---|---|
| TRICIDA, INC. | Corporate Officer/Principal | 01-11-2019 |
| RELYPSA INC | Algemeen Adviseur | 01-11-2015 |
| KYNTRA BIO, INC. | Algemeen Adviseur | 01-01-2010 |
Synergia LLC | Corporate Officer/Principal | 01-01-1995 |
Gore Hybrid Technologies, Inc. | Corporate Officer/Principal | - |
Opleiding van Claire J. Lockey
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary therapeutics for the treatment of serious medical disorders | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Tricida, Inc.
Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Layton BioScience, Inc. | |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Synergia LLC | |
Gore Hybrid Technologies, Inc. |
















